Atectura Inhalation Capsules Medium Dose, an external medicine manufactured by Novartis Pharma, includes budesonide, glycopyrronium bromide, and formoterol fumarate hydrate. It is provided as 1 capsule, bearing YJ code 2290806G2028.
Atectura Inhalation Capsules Medium Dose
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).